Switzerland· 50085074
Aurorix 300
A moclobemide product containing moclobemidum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Moclobemide is registered in 12 of 19 countries.
Countries holding a registration under ATC N06AG02 (moclobemide), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 7 of them publish a price we can compare per daily dose
Moclobemide · ATC N06AG02
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of moclobemide costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), the median price runs from $0.54 in France to $1.38 in Switzerland — a ×2.6 gap.
- Switzerland: $1.38 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Moclobemide · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.38
- FR France$0.54
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- moclobemidum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- N06AG02
- ATC class
- Moclobemide
- Defined daily dose
- 0.3 g, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768050085074460 StkCHF 50.4
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
25 interactions on record for moclobemide.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Moclobemide · interactions on record
25 records
25 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Moclobemide in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAurorixParanova Oy
- CzechiaAURORIXVIATRIS HEALTHCARE LIMITED, Dublin
- NetherlandsMoclobemide Sandoz 300 mg, filmomhulde tablettenSandoz B.V.
- NorwayAurorixViatris AS
- United KingdomManerix 150mg tabletsDowelhurst Ltd
- CanadaMANERIXBAUSCH HEALTH, CANADA INC.
- GermanyAurorixViatris Healthcare Gmbh
- SwedenAurorix 150 mg Filmdragerad tablettEbb Medical AB
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Aurorix
- Belgium · Moclobemide Sandoz
- Czechia · Aurorix
- Germany · Aurorix, Moclobemid 1 A Pharma
- Spain · Manerix
- Finland · Aurorix
- France · Moclamine
- United Kingdom (Northern Ireland) · Manerix, Moclobemide
- Hungary · Aurorix
- Ireland · Manerix
- Netherlands · Moclobemide Sandoz
- Norway · Aurorix
- Poland · Aurorix, Mobemid
- Portugal · Aurorix, Zorix
- Sweden · Aurorix
- Slovenia · Aurorix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e50fcd14-a569-4de4-9252-fdb8a62759e3 GET /v1/drugs/e50fcd14-a569-4de4-9252-fdb8a62759e3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "moclobemidum 300 mg",
"valid_from": "2004-02-01",
"limitations": null,
"galenic_form": "Filmtabl 300 mg",
"therapeutic_area": null,
"sl_inclusion_date": "1998-03-15",
"self_retention_pct": 10
}See everything about moclobemide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.